SCHEMBL18597681

SCHEMBL18597681

Cc1ccc(-c2onc(C)c2NC(=O)OC(C)(C)C)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 5/20 0.52
LPAR3 Q9UBY5 3/20 0.52
MAPT P10636 2/20 0.46
KDM4E B2RXH2 2/20 0.44
ABCC3 O15438 1/20 0.44
ABCC4 O15439 1/20 0.44
ABCB11 O95342 1/20 0.44
CYP2C8 P10632 1/20 0.44
CYP2C9 P11712 1/20 0.44
ABCB4 P21439 1/20 0.44
ABCC2 Q92887 1/20 0.44
SLCO1B3 Q9NPD5 1/20 0.44
SLCO1B1 Q9Y6L6 1/20 0.44
LPAR2 Q9HBW0 2/20 0.43
HDAC3 O15379 3/20 0.40
HDAC1 Q13547 3/20 0.40
HDAC2 Q92769 2/20 0.40
HDAC8 Q9BY41 2/20 0.40
PSMB8 P28062 1/20 0.40
CYP17A1 P05093 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1345 0.90 LPAR1 (0.53) LPAR1LPAR3MAPTKDM4EABCC3
SCHEMBL2292498 0.85 LPAR1 (0.67) LPAR1LPAR3MAPTKDM4EABCC3
SCHEMBL4587 0.82 LPAR1 (0.53) LPAR1LPAR3MAPTKDM4EABCC3
SCHEMBL2796554 0.82 LPAR1 (0.68) LPAR1LPAR3MAPTKDM4EABCC3
SCHEMBL4489 0.82 LPAR1 (0.44) LPAR1LPAR3MAPTKDM4EABCC3
SCHEMBL4037272 0.82 MAPT (0.54) LPAR1LPAR3MAPTKDM4EABCC3
SCHEMBL2800110 0.81 LPAR1 (0.65) LPAR1LPAR3MAPTKDM4EABCC3
SCHEMBL5585 0.80 LPAR1 (0.47) LPAR1LPAR3MAPTKDM4EABCC3
SCHEMBL4163 0.79 LPAR1 (0.54) LPAR1LPAR3MAPTABCC3ABCC4
SCHEMBL5213 0.78 LPAR1 (0.51) LPAR1LPAR3MAPTABCC3ABCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-B1 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS INC (US) 2017-03-08 EP disclosed